Global Antiemetics Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antiemetics market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antiemetics market."
Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning.
These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics.

The global Antiemetics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antiemetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiemetics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    Merck
    Sanofi Aventis
    Bristol Myers Squibb
    Eli Lilly
    Pfizer
    Astellas
    Johnson & Johnson
    Baxter

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    5-HT3 receptor antagonists
    Dopamine antagonists
    NK1 receptor antagonist
    Antihistamines (H1 histamine receptor antagonists)
    Cannabinoids
    Benzodiazepines
    Anticholinergics
    Steroids
    Others

Segment by Application
    Chemotherapy
    Motion sickness
    Gastroenteritis
    General anesthetics
    Opioid analgesics
    Dizziness
    Pregnancy
    Food poisoning
    Emotional stress
    Others